Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214200 · ClinicalTrials.gov registry record · NA
High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01214200 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 20 participants.
The verdict
NCT01214200, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients. The investigators believe that HINPPV, used at least 6 hours nocturnally over three months, will benefit the stable hypercapnic COPD patient through a reduction in the daytime partial pressure of carbon dioxide in arterial blood (PaCO2) levels.
Interventions
- DEVICE Bilevel positive airway pressure (BiPAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214200
The ClinicalTrials.gov registry entry for NCT01214200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bilevel positive airway pressure (BiPAP) is the first listed.
NCT01214200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01214200 about?
NCT01214200 is a clinical study titled "High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)". The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients. The investigators believe that HINPPV, used at least 6 hours nocturnally over three months, will benefit the stable hypercapnic COPD ...
What is the current status of trial NCT01214200?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01214200?
The interventions under investigation include: Bilevel positive airway pressure (BiPAP) (DEVICE).
Who is sponsoring clinical trial NCT01214200?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.